PL3416674T3 - Lek zawierający rekombinowane lektyny jemioły do leczenia guzów mózgu - Google Patents

Lek zawierający rekombinowane lektyny jemioły do leczenia guzów mózgu

Info

Publication number
PL3416674T3
PL3416674T3 PL17710128T PL17710128T PL3416674T3 PL 3416674 T3 PL3416674 T3 PL 3416674T3 PL 17710128 T PL17710128 T PL 17710128T PL 17710128 T PL17710128 T PL 17710128T PL 3416674 T3 PL3416674 T3 PL 3416674T3
Authority
PL
Poland
Prior art keywords
mistellectins
containing recombinant
medicine containing
treating brain
brain tumours
Prior art date
Application number
PL17710128T
Other languages
English (en)
Inventor
Hans Lentzen
Original Assignee
Melema Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melema Pharma Gmbh filed Critical Melema Pharma Gmbh
Publication of PL3416674T3 publication Critical patent/PL3416674T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42Lectins, e.g. concanavalin, phytohaemagglutinin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL17710128T 2016-02-15 2017-02-15 Lek zawierający rekombinowane lektyny jemioły do leczenia guzów mózgu PL3416674T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16155735.0A EP3205348A1 (de) 2016-02-15 2016-02-15 Arzneimittel enthaltend rekombinante mistellektine zur behandlung von hirntumoren
PCT/EP2017/053429 WO2017140739A1 (de) 2016-02-15 2017-02-15 Arzneimittel enthaltend rekombinante mistellektine zur behandlung von hirntumoren
EP17710128.4A EP3416674B1 (de) 2016-02-15 2017-02-15 Arzneimittel enthaltend rekombinante mistellektine zur behandlung von hirntumoren

Publications (1)

Publication Number Publication Date
PL3416674T3 true PL3416674T3 (pl) 2021-06-14

Family

ID=55359452

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17710128T PL3416674T3 (pl) 2016-02-15 2017-02-15 Lek zawierający rekombinowane lektyny jemioły do leczenia guzów mózgu

Country Status (7)

Country Link
US (1) US10722553B2 (pl)
EP (2) EP3205348A1 (pl)
DK (1) DK3416674T3 (pl)
EA (1) EA201891722A1 (pl)
ES (1) ES2856066T3 (pl)
PL (1) PL3416674T3 (pl)
WO (1) WO2017140739A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124470T3 (es) 1995-06-26 1999-02-01 Madaus Ag Koeln Lectina recombinante de muerdago.
DE19804210A1 (de) 1998-02-03 1999-08-12 Biosyn Arzneimittel Gmbh Rekombinante Mistellektine
JP4681226B2 (ja) * 2001-12-21 2011-05-11 ビスカム・アーゲー ヤドリギレクチンに対する個体の応答性を判定する方法
DE102011003478A1 (de) 2011-02-01 2012-08-02 Cytavis Biopharma Gmbh Antivirales Mittel enthaltend rekombinante Mistellektine
EP2508195A1 (de) 2011-04-06 2012-10-10 Cytavis BioPharma GmbH Arzneimittel enthaltend rekombinante Mistellektine zur Behandlung des malignen Melanoms

Also Published As

Publication number Publication date
DK3416674T3 (da) 2021-02-01
WO2017140739A1 (de) 2017-08-24
EP3416674B1 (de) 2020-11-25
US20190046606A1 (en) 2019-02-14
EP3205348A1 (de) 2017-08-16
EP3416674A1 (de) 2018-12-26
EA201891722A1 (ru) 2019-01-31
ES2856066T3 (es) 2021-09-27
US10722553B2 (en) 2020-07-28

Similar Documents

Publication Publication Date Title
IL290149A (en) Combined treatment for cancer
HK1247202A1 (zh) 用於治療癌症的化合物
HK1247129A1 (zh) 治療癌症的聯合療法
IL249065A0 (en) Combination of treatments for cancer treatment
HK1251475A1 (zh) 用於癌症治療的聯合療法
IL255060A0 (en) Combined treatment for cancer
IL249229B (en) Compounds for the treatment of brain cancer
ZA201806819B (en) Pharmaceutical combinations for the treatment of cancer
IL259996A (en) Combinations for cancer treatment
HK1254882A1 (zh) 用於治療癌症的組合療法
IL263407B (en) Pharmaceutical combinations for cancer treatment
IL250576B (en) Immune therapy with specific medical multi-peptides t for the treatment of brain metastases
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
IL260246A (en) A drug for the treatment of myocardial infarction
GB201520600D0 (en) Treatment of central nervous tumours
PL3416674T3 (pl) Lek zawierający rekombinowane lektyny jemioły do leczenia guzów mózgu
IL268897A (en) A drug to treat a malignant tumor
HK1256371A1 (zh) 用於治療腫瘤的方法
GB201700502D0 (en) Treatment of tumours of the central nervous system
GB201523000D0 (en) The combination of chinese medicine for treating dysmenorrhea
GB201511895D0 (en) Combination therapy for treating multiple sclerosis
GB201518002D0 (en) Ketamine for the treatment of somatoform pain disorder
GB201522990D0 (en) The combination of chinese medicine for treating enteritis
GB201519841D0 (en) Treatment of central nervous tumours
GB201523003D0 (en) The combination of chinese medicine for treating bronchitis